EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NRXN1 as a Prognostic Biomarker: Linking Copy Number Variation to EMT and Survival in Colon Cancer

Hyun Jin Bang, Hyun-Jeong Shim iD, Mi-Ra Park, Sumin Yoon iD, Kyung Hyun Yoo, Young-Kook Kim, Hyunju Lee iD, Jeong-Seok Nam iD, Jun-Eul Hwang, Woo-Kyun Bae iD, Ik-Joo Chung, Eun-Gene Sun und 1 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252111423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hyun Jin Bang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Internal Medicine, Chonnam National University Medical School and Hwasun Hospital, Hwasun 58128, R…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, DNA Copy Number Variations, Biomarkers, Tumor, Calcium-Binding Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chonnam National University Hwasun Hospital, National Research Foundation of Korea, Korean government (MSIT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of biomarkers in cancer treatment varies significantly depending on the cancer stage. Thus, in clinical practice, tailoring biomarkers to meet the specific needs and challenges of each cancer stage can increase the precision of treatment. Because they reflect underlying genetic alterations that influence cancer progression, copy number variation (CNV) biomarkers can play crucial prognostic roles. In our previous study, we identified potential survival-related genes for colorectal cancer (CRC) by analyzing CNV and gene expression data using a machine-learning approach. To further investigate the biological function of NRXN1, we assessed the use of RNA sequencing, phosphokinase assays, real-time quantitative PCR, and Western blot analysis. We found that NRXN1 copy number deletion was significantly associated with poor overall survival (OS) and recurrence-free survival (RFS), even in patients who received adjuvant chemotherapy. Compared with its expression in normal tissues, NRXN1 expression was lower in tumors, suggesting its potential role as a tumor suppressor. NRXN1 knockdown enhanced CRC cell viability and invasion, and transcriptome analysis indicated that the increased invasion was caused by GSK3β-mediated epithelial–mesenchymal transition. These findings highlight NRXN1 copy number deletion as a novel biomarker for predicting recurrence and survival in patients with resected colon cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionDNA Copy Number VariationsBiomarkers, TumorCalcium-Binding ProteinsColonic NeoplasmsGene Expression Regulation, NeoplasticHumansPrognosisNeural Cell Adhesion MoleculesCell Line, TumorMaleFemaleMiddle AgedCell Adhesion Molecules, NeuronalGlycogen Synthase Kinase 3 betaAged

Stichwörter der Autor:innen

colorectal cancer (CRC)epithelial–mesenchymal transitionmechanisms of inhibition

Substanzen

Biomarkers, TumorNRXN1 protein, humanCalcium-Binding ProteinsNeural Cell Adhesion MoleculesCell Adhesion Molecules, NeuronalGlycogen Synthase Kinase 3 beta

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Internal Medicine, Chonnam National University Medical School and Hwasun Hospital, Hwasun 58128, Republic of Korea.
  • Laboratory of Biomedical Genomics, Department of Biological Sciences, Sookmyung Women's University, Seoul 04310, Republic of Korea.
  • Department of Biochemistry, Chonnam National University Medical School, Hwasun 58128, Republic of Korea.
  • School of Electrical Engineering and Computer Science, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.
  • School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.
  • National Immunotherapy Innovation Center, Chonnam National University Medical School, Hwasun 58128, Republic of Korea.

ORCID-Profile: Hyun-Jeong Shim, Sumin Yoon, Hyunju Lee, Jeong-Seok Nam, Woo-Kyun Bae

Förderung

  • Chonnam National University Hwasun Hospital
  • National Research Foundation of Korea
  • Korean government (MSIT)
  • Ministry of Education
  • Chonnam National University Hwasun Hospital Institute for Biomedical Science

Zitieren

APA

Bang, H. J., Shim, H. J., Park, M. R., Yoon, S., Yoo, K. H., Kim, Y. K., Lee, H., Nam, J. S., Hwang, J. E., Bae, W. K., Chung, I. J., Sun, E. G., & Cho, S. H. (2024). NRXN1 as a Prognostic Biomarker: Linking Copy Number Variation to EMT and Survival in Colon Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111423

Vancouver

Bang HJ, Shim HJ, Park MR, Yoon S, Yoo KH, Kim YK, et al. NRXN1 as a Prognostic Biomarker: Linking Copy Number Variation to EMT and Survival in Colon Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111423

BibTeX
@article{Bang2024,
  author = {Bang, Hyun Jin and Shim, Hyun-Jeong and Park, Mi-Ra and Yoon, Sumin and Yoo, Kyung Hyun and Kim, Young-Kook and Lee, Hyunju and Nam, Jeong-Seok and Hwang, Jun-Eul and Bae, Woo-Kyun and Chung, Ik-Joo and Sun, Eun-Gene and Cho, Sang-Hee},
  title = {NRXN1 as a Prognostic Biomarker: Linking Copy Number Variation to EMT and Survival in Colon Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252111423}
}
Kostenlos starten →